Skip to main content

Peer Review reports

From: Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

Original Submission
1 Jun 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Jan 2022 Reviewed Reviewer Report - Hitoshi Tsuda
21 Jan 2022 Reviewed Reviewer Report - Mariia D. Ivanova
8 Feb 2022 Author responded Author comments - Virginie Marcel
Resubmission - Version 3
8 Feb 2022 Submitted Manuscript version 3
11 Feb 2022 Author responded Author comments - Virginie Marcel
Resubmission - Version 4
11 Feb 2022 Submitted Manuscript version 4
15 Feb 2022 Author responded Author comments - Virginie Marcel
Resubmission - Version 5
15 Feb 2022 Submitted Manuscript version 5
1 Mar 2022 Reviewed Reviewer Report - Mariia D. Ivanova
23 Mar 2022 Reviewed Reviewer Report - Hitoshi Tsuda
4 Apr 2022 Author responded Author comments - Virginie Marcel
Resubmission - Version 6
4 Apr 2022 Submitted Manuscript version 6
Publishing
11 Apr 2022 Editorially accepted
11 May 2022 Article published 10.1186/s12885-022-09552-x

You can find further information about peer review here.

Back to article page